A comprehensive study on drug-related Raynaud's phenomenon based on the FDA adverse event reporting system
{{output}}
Raynaud's phenomenon (RP) is often an overlooked adverse event, mainly secondary RP, where drug induction or exacerbation is a controllable and preventable factor. This study aimed to systematically evaluate the association between drugs and RP using the FDA ... ...
